The Future of Female Midlife Health: MIDI Health Announces $63 Million Series B Funding Round!

MIDI Health, the pioneering virtual care platform dedicated to enhancing women's health during midlife, is thrilled to announce a substantial funding round that has raised $63 million. This latest infusion of capital will empower the company to broaden its innovative offerings in the realm of female midlife health. As a leader in addressing the unique challenges of perimenopause, menopause, and beyond, MIDI collaborates with top-tier experts to provide a comprehensive, individualized approach that considers each woman's health history, lifestyle, and genetics. The latest funding will be utilized to expand its customized Care Plans, which encompass prescription hormonal and non-hormonal treatments, lifestyle coaching, wellness therapies, supplements, and specialized support for cancer survivors. Additionally, MIDI Health will invest in enhancing its integration with the broader health benefits ecosystem, ensuring that its services remain accessible and affordable for all women through partnerships with employers and major PPO insurance plans. With this new funding, MIDI is determined to revolutionize midlife health care, making it more personalized, holistic, and responsive to women's needs during this critical phase of their lives and careers. As the only platform focused exclusively on female midlife health, MIDI is stepping up to ensure that millions of women are empowered with the care and resources they deserve while navigating the complexities of midlife transitions.